Analytical Data
-
Gene name
MTMR9
- Application
-
Alternative Names
C8orf9; MTMR8; LIP-STYX
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Z2D0
-
Expression Region
Met1~Ser167
-
Molecular Weight
23kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MTMR9, a member of the myotubularin-related protein family, has garnered significant interest in recent years due to its role in cellular processes such as lipid metabolism, membrane trafficking, and endosomal dynamics. Initially identified for its involvement in neuronal functions, MTMR9 has been linked to various physiological and pathological conditions, including neurodegenerative diseases and metabolic disorders. Its enzymatic activity, particularly its phosphoinositide phosphatase function, suggests a crucial role in regulating cellular signaling pathways that involve lipid modifications. Research has demonstrated that mutations in the MTMR9 gene can lead to myopathy and other muscle-related disorders, highlighting its importance in muscle health and function. Moreover, the potential for MTMR9 to serve as a therapeutic target has drawn attention from researchers seeking novel strategies to modulate its activity for disease intervention. The recombinant expression of MTMR9 protein enables detailed studies of its structure-function relationships and interactions with other cellular components, thereby advancing our understanding of its biological significance and potential medicinal applications. Ongoing investigations aim to elucidate the molecular mechanisms underlying MTMR9’s functions, which may pave the way for developing targeted therapies that harness its potential in treating related diseases. The evolving landscape of MTMR9 research holds promise for uncovering new insights into cellular regulation and therapeutic advancements.
